Class information for:
Level 1: ZOLEDRONIC ACID//SKELETAL RELATED EVENTS//BONE METASTASES

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
1189 2698 40.2 78%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
1423 7465 BISPHOSPHONATES//ZOLEDRONIC ACID//BISPHOSPHONATE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ZOLEDRONIC ACID Author keyword 302 49% 17% 448
2 SKELETAL RELATED EVENTS Author keyword 181 80% 4% 111
3 BONE METASTASES Author keyword 156 30% 16% 433
4 SKELETAL RELATED EVENT Author keyword 89 92% 1% 35
5 BISPHOSPHONATES Author keyword 85 17% 18% 474
6 BONE METASTASIS Author keyword 56 20% 10% 258
7 BISPHOSPHONATE Author keyword 39 15% 9% 244
8 METASTATIC BONE DISEASE Author keyword 37 56% 2% 44
9 PAMIDRONATE Author keyword 36 25% 5% 123
10 UNIT CLIN ONCOL Address 34 35% 3% 78

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 ZOLEDRONIC ACID 302 49% 17% 448 Search ZOLEDRONIC+ACID Search ZOLEDRONIC+ACID
2 SKELETAL RELATED EVENTS 181 80% 4% 111 Search SKELETAL+RELATED+EVENTS Search SKELETAL+RELATED+EVENTS
3 BONE METASTASES 156 30% 16% 433 Search BONE+METASTASES Search BONE+METASTASES
4 SKELETAL RELATED EVENT 89 92% 1% 35 Search SKELETAL+RELATED+EVENT Search SKELETAL+RELATED+EVENT
5 BISPHOSPHONATES 85 17% 18% 474 Search BISPHOSPHONATES Search BISPHOSPHONATES
6 BONE METASTASIS 56 20% 10% 258 Search BONE+METASTASIS Search BONE+METASTASIS
7 BISPHOSPHONATE 39 15% 9% 244 Search BISPHOSPHONATE Search BISPHOSPHONATE
8 METASTATIC BONE DISEASE 37 56% 2% 44 Search METASTATIC+BONE+DISEASE Search METASTATIC+BONE+DISEASE
9 PAMIDRONATE 36 25% 5% 123 Search PAMIDRONATE Search PAMIDRONATE
10 DENOSUMAB 31 25% 4% 106 Search DENOSUMAB Search DENOSUMAB

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 SKELETAL COMPLICATIONS 399 64% 14% 391
2 ORAL CLODRONATE 234 85% 5% 122
3 ZOLEDRONIC ACID 200 26% 24% 653
4 ADJUVANT CLODRONATE TREATMENT 156 78% 4% 103
5 SKELETAL RELATED EVENTS 135 65% 5% 129
6 ADVANCED MULTIPLE MYELOMA 116 64% 4% 115
7 PAMIDRONATE 80 24% 11% 292
8 METASTATIC BONE DISEASE 64 52% 3% 87
9 BISPHOSPHONATES 63 16% 14% 369
10 CLODRONATE 59 36% 5% 133

Journals



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 JOURNAL OF BONE ONCOLOGY 13 43% 1% 23

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel 2008 231 113 72%
Effects of Bone-Targeted Agents on Cancer Progression and Mortality 2012 48 69 72%
Bisphosphonates in breast cancer 2015 3 48 69%
Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis 2013 24 49 61%
The Key Role of Bisphosphonates in the Supportive Care of Cancer Patients 2014 8 153 78%
Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis 2013 26 38 50%
Metastasis to bone: Causes, consequences and therapeutic opportunities 2002 1098 59 29%
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature 2012 32 87 72%
Mechanisms of disease: Mechanisms of bone metastasis 2004 802 78 24%
Bisphosphonates and cancer-induced bone disease: Beyond their antiresorptive activity 2005 132 19 89%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 UNIT CLIN ONCOL 34 35% 2.9% 78
2 WESTON PK HOSP 17 39% 1.3% 34
3 CLIN ENDOCRINOL BONE DIS 6 71% 0.2% 5
4 SUPPORT CARE CLIN 4 47% 0.3% 7
5 CR UK YCR SHEFFIELD CANC 3 35% 0.3% 8
6 MULTIPLE MYELOMA BONE METASTASIS PROGRAM 3 100% 0.1% 3
7 YORKSHIRE CANC CLIN ONCOL 3 45% 0.2% 5
8 OSTEONCOL RARE TUMORS 3 38% 0.2% 6
9 ENDOCRINOL BREAST CANC 3 60% 0.1% 3
10 OSTEOONCOL 3 60% 0.1% 3

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000216332 OSTEOBLASTIC METASTASIS//3 D COLLAGEN//AHTO 7
2 0.0000210830 BRONJ//OSTEONECROSIS OF THE JAW//ONJ
3 0.0000105013 BONE TARGETING//OSTEOTROPIC DRUG DELIVERY SYSTEM//FARNESYL PYROPHOSPHATE SYNTHASE
4 0.0000094482 UNIT MUSCULOSKELETAL SURG//IMPENDING FRACTURE//PATHOLOGIC FRACTURE
5 0.0000089303 NEUROSYST//MOL NEUROBIOL PAIN//BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE
6 0.0000088802 MYELOMA BONE DISEASE//CAM DR//HEIM
7 0.0000081656 ALENDRONATE//RISEDRONATE//BISPHOSPHONATES
8 0.0000080110 RHENIUM 186 HEDP//BONE PAIN PALLIATION//STRONTIUM 89
9 0.0000072674 PARATHYROID HORMONE RELATED PROTEIN//PTHRP//PARATHYROID HORMONE RELATED PEPTIDE
10 0.0000064564 PALLIATIVE RADIOTHERAPY//FACILITY SURVEY//PAIN FLARE